celecoxib has been researched along with Triple Negative Breast Neoplasms in 3 studies
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although triple-negative breast cancer accounts for less than one-fifth of breast cancers, it has a higher rate of metastasis and mortality." | 5.91 | Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells. ( Hedayat, M; Jafari, R; Khezri, MR; Majidi Zolbanin, N; Malekinejad, H, 2023) |
| "Although triple-negative breast cancer accounts for less than one-fifth of breast cancers, it has a higher rate of metastasis and mortality." | 1.91 | Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells. ( Hedayat, M; Jafari, R; Khezri, MR; Majidi Zolbanin, N; Malekinejad, H, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallyas, F | 1 |
| Ramadan, FHJ | 1 |
| Andreidesz, K | 1 |
| Hocsak, E | 1 |
| Szabo, A | 1 |
| Tapodi, A | 1 |
| Kiss, GN | 1 |
| Fekete, K | 1 |
| Bognar, R | 1 |
| Szanto, A | 1 |
| Bognar, Z | 1 |
| Balamurugan, K | 1 |
| Poria, DK | 1 |
| Sehareen, SW | 1 |
| Krishnamurthy, S | 1 |
| Tang, W | 1 |
| McKennett, L | 1 |
| Padmanaban, V | 1 |
| Czarra, K | 1 |
| Ewald, AJ | 1 |
| Ueno, NT | 1 |
| Ambs, S | 1 |
| Sharan, S | 1 |
| Sterneck, E | 1 |
| Hedayat, M | 1 |
| Khezri, MR | 1 |
| Jafari, R | 1 |
| Malekinejad, H | 1 |
| Majidi Zolbanin, N | 1 |
3 other studies available for celecoxib and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Involvement of Mitochondrial Mechanisms and Cyclooxygenase-2 Activation in the Effect of Desethylamiodarone on 4T1 Triple-Negative Breast Cancer Line.
Topics: Amiodarone; Animals; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Surviva | 2022 |
Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer.
Topics: Cadherins; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Female; Glycogen Synthase Ki | 2023 |
Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Celecoxib; Cell Line, Tumor; Fem | 2023 |